Biology in three dimensions
We speak to Jay Gerlach of NanoString technologies about the translational research applications of DNA, RNA, and protein
New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.
We speak to Jay Gerlach of NanoString technologies about the translational research applications of DNA, RNA, and protein
New course from the Wellcome Genome Campus aims to bridge the gap between academic innovation in genomics, and commercial success
Congenica’s role in developing genomic diagnostics has been recognised by the life sciences industry in the prestigious OBN Awards.
CRISPR is covered by new patents issued to Cellectis, the company claims
New genetic test promises to tell you how well you are ageing based on the length of your telomeres
Theranos pivot from consumer-focused blood testing to bringing miniLab platform to hospitals
Theranos, 23andMe, and Zenefits: why are medical startups still struggling?
Gain insights from the world’s leading precision medicine initiatives, hear advances in predictive modeling, and how a working internet of DNA improves clinical validation
New episode of Signal podcast calls shenanigans on the tactics that drug companies use to stay ahead in the market
Color Genomics announce investment round of $45M led by General Catalyst with participation from the U2 front man
Straight out of San Diego, California, comes next-generation mapping for structural variations in the genome
As founder of three different data-driven companies, Atul Butte knows a thing or two about biotech entrepreneurship
Festival of Genomics California is here once again, and we’ve got the inside scoop on what makes San Diego such a special place for genomics
Oh, it’s that time again… from precision oncology to the Million Veteran Program, enjoy our pick of week’s best science bits!
UC Berkeley look to subpoena George Church as part of on-going CRISPR patent dispute